Clinuvel Pharmaceuticals (CUV) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CUV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CUV News, Analysis, Announcements & Results | Clinuvel Pharmaceuticals Limited | AFR - Financial ReviewJune 25, 2025 | afr.comClinuvel Pharmaceuticals Stock Price HistoryMay 28, 2025 | investing.comClinuvel Pharmaceuticals Limited: CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105May 7, 2025 | finanznachrichten.deBiocurious: FDA approval remains the Holy Grail for ASX life science stocksMarch 18, 2025 | msn.comHigh Growth Tech Stocks In Australia For March 2025March 16, 2025 | finance.yahoo.comClinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025March 4, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Mesoblast Limited (OtherMEOBF) and Clinuvel Pharmaceuticals Limited (OtherCLVLF)February 27, 2025 | markets.businessinsider.comASX Growth Companies With High Insider Ownership In January 2025January 27, 2025 | finance.yahoo.comHealth Check: Local biotech starred in 2024, but the rising tide did not lift all boatsJanuary 1, 2025 | msn.comClinuvel Pursues Expanded SCENESSE® Dosage in EuropeNovember 20, 2024 | markets.businessinsider.comClinuvel Pharmaceuticals Tackles Market Challenges and OpportunitiesNovember 17, 2024 | markets.businessinsider.comClinuvel Pharmaceuticals Refocuses on Core Programs for GrowthNovember 17, 2024 | markets.businessinsider.comMA Financial Group Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)October 30, 2024 | markets.businessinsider.comHealth Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging dealOctober 1, 2024 | msn.comTop Growth Companies With Significant Insider OwnershipSeptember 28, 2024 | finance.yahoo.comSeptember 2024's Top Growth Picks With High Insider OwnershipSeptember 20, 2024 | finance.yahoo.comClinuvel Pharmaceuticals (ASX:CUV) Posted Healthy Earnings But There Are Some Other Factors To Be Aware OfSeptember 11, 2024 | finance.yahoo.com3 High Growth ASX Companies With Significant Insider OwnershipSeptember 8, 2024 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: Impedimed Limited (IPDQF), Clinuvel Pharmaceuticals Limited (CLVLF)September 4, 2024 | markets.businessinsider.comClinuvel Pharmaceuticals Full Year 2024 Earnings: Beats ExpectationsSeptember 2, 2024 | finance.yahoo.comClinuvel Pharmaceuticals Limited (CUV.AX)September 2, 2024 | ca.finance.yahoo.comGuess which ASX All Ords healthcare share just rocketed 13% on its FY 2024 results!August 28, 2024 | msn.comMorgans upgrades Clinuvel Pharmaceuticals Limited (CLVLF) to a BuyAugust 26, 2024 | markets.businessinsider.comWhere to find value opportunities in Australian healthcare and 3 stocks to watchAugust 8, 2024 | msn.com3 High Insider Ownership Growth Companies With 18% Revenue IncreaseJuly 26, 2024 | finance.yahoo.comHigh Insider Ownership Growth Stocks On The ASX For July 2024July 24, 2024 | finance.yahoo.comiShares Gold Producers UCITS ET (IS0E.SG)May 4, 2024 | finance.yahoo.com2 undiscovered stocks (and how to analyse under-the-radar companies)April 28, 2024 | msn.comMalibu shines a light on CLINUVEL’s pioneering work in photomedicineMarch 5, 2024 | finance.yahoo.comDr Boreham’s Crucible: Does Clinuvel’s investor value run deeper than just ‘makes Scenesse’?March 4, 2024 | msn.comClinuvel Pharmaceuticals Ltd CUVFebruary 28, 2024 | morningstar.comMWhy Clinuvel, Medibank, Sayona Mining, and Tabcorp shares are sinking todayFebruary 22, 2024 | fool.com.auAustralia stocks higher at close of trade; S&P/ASX 200 up 0.04%February 22, 2024 | msn.comShort & Caught: Pilbara Minerals ASX’s most shorted as lithium stocks targetedJanuary 3, 2024 | msn.comLooking for ASX growth shares to buy? These could rise ~30%December 7, 2023 | fool.com.auDown 25% in a month, is this ASX 300 company about to sue the UK Government?September 20, 2023 | fool.com.auWhy the Clinuvel Pharmaceuticals share price crashed 11% lower todaySeptember 1, 2023 | fool.com.auWilsons Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)September 1, 2023 | markets.businessinsider.comClinuvel Pharmaceuticals Limited (CLVLF) Gets a Buy from WilsonsMay 4, 2023 | markets.businessinsider.comWILSONS Maintains Clinuvel Pharmaceuticals (ASX:CUV) Overweight RecommendationApril 21, 2023 | msn.comInstitutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV) shares but individual investors control 54% of the companyApril 16, 2023 | finance.yahoo.comWilsons Sticks to Their Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)April 4, 2023 | markets.businessinsider.comHere's Why We Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention TodayMarch 14, 2023 | finance.yahoo.comCUV.AX - | Stock Price & Latest News | ReutersFebruary 7, 2023 | reuters.comCLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned IndividualsFebruary 1, 2023 | finance.yahoo.comClinuvel Pharmaceuticals Limited: CLINUVEL Trial Results Show Drug Reduces DNA DamageJanuary 16, 2023 | finanznachrichten.deClinuvel Pharmaceuticals Limited's (ASX:CUV) Stock Has Fared Decently: Is the Market Following Strong Financials?November 24, 2022 | finance.yahoo.comClinuvel Pharmaceuticals LimitedNovember 18, 2022 | afr.comWhile institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV), individual investors are its largest shareholders with 54% ownershipNovember 7, 2022 | finance.yahoo.comClinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Is Looking A Bit Stretched At The MomentOctober 20, 2022 | finance.yahoo.com Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CUV and its competitors with MarketBeat's FREE daily newsletter. Email Address CUV Media Mentions By Week CUV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CUV News Sentiment▼0.000.55▲Average Medical News Sentiment CUV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CUV Articles This Week▼00▲CUV Articles Average Week Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CUV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genus News Today Oxford Nanopore Technologies News Today Biotest Aktiengesellschaft News Today PureTech Health News Today Oxford Biomedica News Today Faron Pharmaceuticals Oy News Today Fennec Pharmaceuticals News Today Cybin News Today NervGen Pharma News Today Bioventix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CUV) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clinuvel Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Clinuvel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
